Terry Hyslop Selected Research

Lymphatic Metastasis

7/2015	Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
10/2012	Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes.
11/2009	GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients.
2/2009	Association of GUCY2C expression in lymph nodes with time to recurrence and disease-free survival in pN0 colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Terry Hyslop Research Topics

Disease

72	Neoplasms (Cancer) 01/2024 - 08/2003
39	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2008
21	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 09/2005
14	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2010
10	Neoplasm Metastasis (Metastasis) 12/2018 - 08/2006
8	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2023 - 06/2004
6	Carcinogenesis 11/2014 - 09/2007
5	Pathologic Complete Response 01/2022 - 10/2018
4	Papillary Thyroid Cancer 11/2019 - 01/2015
4	Lymphatic Metastasis 07/2015 - 02/2009
4	Adenocarcinoma 02/2014 - 08/2009
3	Thyroid Neoplasms (Thyroid Cancer) 11/2019 - 01/2017
3	Colonic Neoplasms (Colon Cancer) 01/2019 - 09/2007
3	Melanoma (Melanoma, Malignant) 01/2018 - 01/2012
2	Infections 05/2024 - 07/2017
2	Triple Negative Breast Neoplasms 01/2023 - 01/2022
2	Circulating Neoplastic Cells 01/2021 - 01/2018
2	Erectile Dysfunction 03/2015 - 01/2015
2	Glioma (Gliomas) 02/2013 - 06/2010
2	Pancreatic Fistula (Pancreatic Fistulas) 01/2013 - 05/2009
2	Carcinoma (Carcinomatosis) 01/2013 - 01/2010
2	Fistula 01/2013 - 05/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2011 - 08/2009
2	Meningioma (Meningiomas) 05/2010 - 08/2003
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2007 - 05/2007
2	Neoplasm Micrometastasis 08/2006 - 09/2005
2	Lacerations 04/2003 - 03/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	Inflammatory Breast Neoplasms 02/2020

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2003
15	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2004
12	Hormones (Hormone)IBA 01/2024 - 08/2003
10	Messenger RNA (mRNA)IBA 01/2022 - 12/2005
10	Enterotoxin ReceptorsIBA 02/2013 - 09/2005
6	MicroRNAs (MicroRNA)IBA 01/2018 - 03/2004
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 11/2014 - 09/2005
5	Estrogen ReceptorsIBA 01/2023 - 09/2011
5	Protein Isoforms (Isoforms)IBA 01/2020 - 06/2003
4	ErbB Receptors (EGF Receptor)IBA 01/2024 - 08/2003
4	VaccinesIBA 01/2020 - 12/2016
4	Tyrosine (L-Tyrosine)FDA Link 10/2016 - 06/2011
3	Epidermal Growth Factor (EGF)IBA 01/2021 - 01/2013
3	Transcription Factors (Transcription Factor)IBA 10/2019 - 04/2010
3	LigandsIBA 10/2019 - 04/2007
3	Guanylate Cyclase (Guanylyl Cyclase)IBA 01/2018 - 02/2009
3	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2013 - 06/2011
3	CyclinsIBA 05/2010 - 08/2008
3	Enterotoxins (Enterotoxin)IBA 12/2006 - 09/2005
2	human ERBB2 proteinIBA 10/2023 - 10/2018
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
2	Dihydrotachysterol (AT 10)IBA 01/2023 - 08/2011
2	AntibodiesIBA 12/2020 - 01/2019
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 10/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2006
2	AntigensIBA 01/2020 - 01/2019
2	ProlactinIBA 12/2018 - 01/2013
2	Phenobarbital (Luminal)FDA Link 11/2017 - 01/2013
2	Indicators and Reagents (Reagents)IBA 07/2015 - 01/2013
2	Sorafenib (BAY 43-9006)FDA Link 02/2013 - 12/2010
2	AndrogensIBA 01/2013 - 01/2012
2	Cyclin D1IBA 05/2010 - 08/2008
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2003 - 08/2003
1	Virulence Factors (Pathogenicity Factors)IBA 05/2024
1	CytokinesIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Biological FactorsIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 11/2021
1	Potassium Channels (Potassium Channel)IBA 11/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2021
1	LipidsIBA 11/2021
1	Abiraterone AcetateIBA 01/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2021
1	Letrozole (Femara)FDA LinkGeneric 01/2020
1	Combined VaccinesIBA 01/2020

Therapy/Procedure

27	Therapeutics 01/2023 - 12/2006
16	Radiotherapy 10/2023 - 08/2003
10	Drug Therapy (Chemotherapy) 01/2024 - 06/2010
7	Neoadjuvant Therapy 01/2022 - 10/2018
6	Segmental Mastectomy (Lumpectomy) 10/2023 - 11/2017
6	Adjuvant Chemotherapy 01/2023 - 11/2009
5	Aftercare (After-Treatment) 10/2023 - 02/2013
5	Mastectomy (Mammectomy) 10/2023 - 01/2019
5	Thyroidectomy 11/2019 - 01/2015
4	Lymph Node Excision (Lymph Node Dissection) 10/2019 - 01/2012
3	Castration 01/2024 - 01/2021
3	Pancreaticoduodenectomy 08/2009 - 02/2009
2	Length of Stay 01/2019 - 01/2013
2	Prostatectomy (Retropubic Prostatectomy) 03/2015 - 01/2015
2	Episiotomy 04/2003 - 03/2002
2	Surgical Instruments (Clip) 04/2003 - 03/2002
1	Time-to-Treatment 01/2021
1	Combined Modality Therapy 02/2020
1	Immunotherapy 01/2020